Last reviewed · How we verify
Treatment of chronic pain associated with adult patients with multiple sclerosis — Treatment Landscape & Competitive Intelligence
1 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Bat | bat | Pfizer | Unknown | Unknown |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Pfizer · 1 drug in Treatment of chronic pain associated with adult patients with multiple sclerosis
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Treatment of chronic pain associated with adult patients with multiple sclerosis:
- Treatment of chronic pain associated with adult patients with multiple sclerosis treatment updates — RSS
- Treatment of chronic pain associated with adult patients with multiple sclerosis treatment updates — Atom
- Treatment of chronic pain associated with adult patients with multiple sclerosis treatment updates — JSON
Cite this brief
Drug Landscape (2026). Treatment of chronic pain associated with adult patients with multiple sclerosis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/treatment-of-chronic-pain-associated-with-adult-patients-with-multiple-sclerosis. Accessed 2026-06-10.
Related
- Treatment of chronic pain associated with adult patients with multiple sclerosis full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing